Quantifying unmet treatment needs among people living with HIV in Australia and other countries
Introduction We examined unmet needs among persons living with HIV (PLHIV) in Australia and compared them with other countries. Methods The 2019 Positive Perspectives web-based survey of PLHIV on antiretroviral therapy (ART) was conducted in 25 countries and included 120 participants from Australia...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
European Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/a95267733cc14acbae1f759bf1cac6b2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Introduction
We examined unmet needs among persons
living with HIV (PLHIV) in Australia and compared them with
other countries.
Methods
The 2019 Positive Perspectives web-based survey
of PLHIV on antiretroviral therapy (ART) was conducted in
25 countries and included 120 participants from Australia.
Descriptive analyses were used to explore treatment-related
attitudes and behaviors among participants in Australia
versus other countries.
Results
Despite most Australian participants reporting viral
suppression (96.7%; 116/120) and treatment satisfaction
(83.3%; 100/120), unmet needs existed, with 35.0%
(42/120) reporting suboptimal mental health and 42.5%
(51/120) perceiving gaps in their HIV management. Side
effects were the most common reason for switching ART
among Australian participants who ever switched (54.4%;
56/103) alongside reducing the number of pills (33.0%;
34/103) and medicines (25.2%; 26/103). Australian
participants with polypharmacy reported a higher
prevalence of being worried about taking more and more
medicines with age, than those without polypharmacy
[58.1% (36/62) vs 37.7% (22/58), p=0.027]; they were also
more open to ART with fewer medicines [91.9% (57/62) vs
77.6% (45/58), p=0.028]. Participants fully informed and
involved in treatment planning generally reported better
health outcomes than those with less engagement with
their providers. For example, within the Australian sample,
compared to those neither informed nor involved in care,
those fully involved reported significantly higher treatment
satisfaction [89.0% (81/91) vs 57.9% (11/19), p=0.032],
greater sentiment that their personal needs were met by
their provider [94.5% (86/91) vs 52.6% (10/19), p=0.012],
and higher optimal overall health [70.3% (64/91) vs 36.8%
(7/19), p=0.032]; they were also less likely to report being
stressed by their daily dosing schedule [11.0% (10/91) vs
47.4% (9/19), p=0.001]. Australian participants reported the
highest percentage (93.3%; 42/45) of those reporting that
they discussed with their provider a treatment they wanted,
among those indicating they ever wanted a new treatment.
Conclusions
Holistic care addressing salient treatmentrelated
issues, as well as patient preferences and concerns
can help improve PLHIV’s health-related quality of life, the
fourth ‘90’ target. |
|---|